BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18372118)

  • 1. Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells.
    Shepherd TG; Thériault BL; Nachtigal MW
    Gene; 2008 May; 414(1-2):95-105. PubMed ID: 18372118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of bone morphogenetic protein 2 (BMP2) stimulated inhibitor of DNA binding 3 (Id3) transcription.
    Ho CC; Zhou X; Mishina Y; Bernard DJ
    Mol Cell Endocrinol; 2011 Jan; 332(1-2):242-52. PubMed ID: 21056086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKX2.1 regulates transcription of the gene for human bone morphogenetic protein-4 in lung epithelial cells.
    Zhu NL; Li C; Xiao J; Minoo P
    Gene; 2004 Feb; 327(1):25-36. PubMed ID: 14960358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas.
    Arnold JM; Mok SC; Purdie D; Chenevix-Trench G
    Br J Cancer; 2001 Feb; 84(3):352-9. PubMed ID: 11161400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of BMP signalling in the control of ID3 expression in the hair follicle.
    O'Shaughnessy RF; Christiano AM; Jahoda CA
    Exp Dermatol; 2004 Oct; 13(10):621-9. PubMed ID: 15447722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation.
    Samanta J; Kessler JA
    Development; 2004 Sep; 131(17):4131-42. PubMed ID: 15280210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells.
    Thériault BL; Shepherd TG; Mujoomdar ML; Nachtigal MW
    Carcinogenesis; 2007 Jun; 28(6):1153-62. PubMed ID: 17272306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
    J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter.
    Pan Q; Yu Y; Chen Q; Li C; Wu H; Wan Y; Ma J; Sun F
    J Cell Physiol; 2008 Oct; 217(1):228-41. PubMed ID: 18506848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta.
    Yokota T; Bui T; Liu Y; Yi M; Hunt KK; Keyomarsi K
    Cancer Res; 2007 Dec; 67(23):11272-83. PubMed ID: 18056453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Id3 is a novel regulator of p27kip1 mRNA in early G1 phase and is required for cell-cycle progression.
    Chassot AA; Turchi L; Virolle T; Fitsialos G; Batoz M; Deckert M; Dulic V; Meneguzzi G; Buscà R; Ponzio G
    Oncogene; 2007 Aug; 26(39):5772-83. PubMed ID: 17404577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the calcium-binding protein S100P is regulated by bone morphogenetic protein in pancreatic duct epithelial cell lines.
    Hamada S; Satoh K; Hirota M; Fujibuchi W; Kanno A; Umino J; Ito H; Satoh A; Kikuta K; Kume K; Masamune A; Shimosegawa T
    Cancer Sci; 2009 Jan; 100(1):103-10. PubMed ID: 19018761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an epithelial-specific enhancer regulating ESX expression.
    Neve RM; Parmar H; Amend C; Chen C; Rizzino A; Benz CC
    Gene; 2006 Feb; 367():118-25. PubMed ID: 16307850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells.
    de Nigris F; Botti C; Rossiello R; Crimi E; Sica V; Napoli C
    Oncogene; 2007 Jan; 26(3):382-94. PubMed ID: 16878156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic proteins promote gliosis in demyelinating spinal cord lesions.
    Fuller ML; DeChant AK; Rothstein B; Caprariello A; Wang R; Hall AK; Miller RH
    Ann Neurol; 2007 Sep; 62(3):288-300. PubMed ID: 17696121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration.
    Rothhammer T; Poser I; Soncin F; Bataille F; Moser M; Bosserhoff AK
    Cancer Res; 2005 Jan; 65(2):448-56. PubMed ID: 15695386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLF4 positively regulates human ghrelin expression.
    Lee HJ; Kang YM; Moon CS; Joe MK; Lim JH; Suh YH; Song J; Jung MH
    Biochem J; 2009 May; 420(3):403-11. PubMed ID: 19327128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engagement of membrane immunoglobulin enhances Id3 promoter activity in WEHI-231 B lymphoma cells.
    Li XJ; Hata K; Mizuguchi J
    Acta Pharmacol Sin; 2005 Apr; 26(4):486-91. PubMed ID: 15780199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short nucleotide polymorphic insertions in the MCL-1 promoter affect gene expression.
    Saxena A; Moshynska OV; Moshynskyy ID; Neuls ED; Qureshi T; Bosch M; Voralia M; Bonham K
    Cancer Lett; 2007 Jun; 251(1):114-31. PubMed ID: 17198743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative genomics on BMP4 orthologs.
    Katoh Y; Katoh M
    Int J Oncol; 2005 Aug; 27(2):581-5. PubMed ID: 16010442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.